Zining Li, Zining Li, Zining Li, Jialiang Gao, Jialiang Gao, Jialiang Gao, . . . Haixia Li. (2022). LncRNA MEG3: Potential stock for precision treatment of cardiovascular diseases. Frontiers Media S.A..
Chicago Style (17th ed.) CitationZining Li, et al. LncRNA MEG3: Potential Stock for Precision Treatment of Cardiovascular Diseases. Frontiers Media S.A., 2022.
MLA (9th ed.) CitationZining Li, et al. LncRNA MEG3: Potential Stock for Precision Treatment of Cardiovascular Diseases. Frontiers Media S.A., 2022.
Warning: These citations may not always be 100% accurate.